UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                   FORM 8-K

                                 CURRENT REPORT
   Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     Date of Report (Date of earliest event reported)     March 5, 2008

                           ON THE GO HEALTHCARE, INC.
           (Exact name of registrant as specified in its charter)

     DELAWARE                      333-61538                 98-0231687
  ----------------             --------------------    -------------------
  (State or Other                 (Commission          (IRS Employer
  Jurisdiction of                 File Number)           Identification
   Incorporation)                                            No.)

                         85 Corstate Avenue, Unit #1
                              Concord, Ontario
                               Canada L4K 4Y2
              ---------------------------------------------------
              (Address of principal executive offices) (Zip Code)


     Registrant's telephone number, including area code:  (905) 760-2987

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))


                    ----------------------------------------

ITEM 1.01       ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

On December 6, 2006, we issued to Dutchess Private Equities Fund, L.P. a
promissory note in the amount of $1,937,000 for a purchase price of $1,550,000.
The note was due and payable in full on July 11, 2008. Other than the $387,000
discount inherent in the purchase price, the note was non-interest bearing.
The note was to be repaid in payments of $60,000 U.S. per month for the
first seven months and $126,500 U.S. per month for the remaining months
until the note was paid in full. In connection with the note, we issued
400,000 shares of restricted common stock as incentive shares.

On March 5, 2008, we agreed to amend the terms of the note. Pursuant to the
terms of the amended note, payments made by us in satisfaction of the note
will be in shares of our common stock, which we will issue to Dutchess on the
tenth calendar day of each month until our obligations under the note have
been satisfied in full.  Each payment will be convertible at eighty percent
of the lowest closing best bid prices of our common stock for the ten trading
days prior to the payment due date.  The maturity date of the note remains the
same. As of March 5, 2008, we owed $632,500 on the note.

<PAGE>

The foregoing description of the terms and conditions of the promissory note
is qualified in its entirety by, and made subject to, the more complete
information set forth in the Convertible Promissory Note filed as Exhibit 4.29,
to the Form 10-KSB filed December 12, 2006 and incorporated herein by
reference.  The foregoing description of the terms and conditions of the
amended promissory note is qualified in its entirety by, and made subject
to, the more complete information set forth in the Amended Convertible
Promissory Note filed as Exhibit 4.2 and incorporated herewith.

This report may contain forward-looking statements that involve risks and
uncertainties.  You should not place undue reliance on these forward-looking
statements.  Our actual results could differ materially from those anticipated
in the forward-looking statements for many reasons including the risks
described in our annual report on Form 10-K and other filings we make from
time to time filed with the Securities and Exchange Commission. Although we
believe the expectations reflected in the forward-looking statements are
reasonable, they relate only to events as of the date on which the statements
are made.  We do not intend to update any of the forward-looking statements
after the date of this document to conform these statements to actual results
or to changes in our expectations, except as required by law.


ITEM 9.01               EXHIBITS.

EXHIBIT
NUMBER                              DESCRIPTION

4.1     Convertible Promissory Note between the Company and Dutchess Private
        Equities Fund, L.P., dated December 6, 2006 (included as Exhibit 4.29
        to the Form 10-KSB filed December 12, 2006 and incorporated herein
        by reference).

4.2     Amended Convertible Promissory Note between the Company and Dutchess
        Private Equities Fund, L.P., dated March 5, 2008 (filed herewith).


                                     SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                          On The Go Healthcare, Inc.
                                          --------------------------
                                                (Registrant)

Date    March 6, 2008

                                               /s/ Stuart Turk
                                          --------------------------
                                                 (Signature)

                                           Name: Stuart Turk
                                          Title: Chief Executive Officer and
                                                 President

<PAGE>
[{"type": "8-K", "sequence": "1", "filename": "dutchess_8kmarch62008.txt", "description": "DUTCHESS NOTE 8K DATED MARCH 5, 2008", "secsgml_size_bytes": 5887}]
{"company-data": {"conformed-name": "ON THE GO HEALTHCARE INC", "cik": "0001126302", "assigned-sic": "5045", "irs-number": "980231687", "fiscal-year-end": "0731"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-61538", "film-number": "08671517"}, "business-address": {"street1": "85 CORSTATE AVENUE UNIT 1", "city": "CONCORD ONT. CANADA", "state": "A6", "zip": "L4K 4Y2", "phone": "905 669 7979 EXT 400"}, "mail-address": {"street1": "85 CORSTATE AVENUE UNIT 1", "city": "CONCORD ONT. CANADA", "state": "A6", "zip": "L4K 4Y2"}}
UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                   FORM 8-K

                                 CURRENT REPORT
   Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     Date of Report (Date of earliest event reported)     March 5, 2008

                           ON THE GO HEALTHCARE, INC.
           (Exact name of registrant as specified in its charter)

     DELAWARE                      333-61538                 98-0231687
  ----------------             --------------------    -------------------
  (State or Other                 (Commission          (IRS Employer
  Jurisdiction of                 File Number)           Identification
   Incorporation)                                            No.)

                         85 Corstate Avenue, Unit #1
                              Concord, Ontario
                               Canada L4K 4Y2
              ---------------------------------------------------
              (Address of principal executive offices) (Zip Code)

     Registrant's telephone number, including area code:  (905) 760-2987

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

                    ----------------------------------------

ITEM 1.01       ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

On December 6, 2006, we issued to Dutchess Private Equities Fund, L.P. a
promissory note in the amount of $1,937,000 for a purchase price of $1,550,000.
The note was due and payable in full on July 11, 2008. Other than the $387,000
discount inherent in the purchase price, the note was non-interest bearing.
The note was to be repaid in payments of $60,000 U.S. per month for the
first seven months and $126,500 U.S. per month for the remaining months
until the note was paid in full. In connection with the note, we issued
400,000 shares of restricted common stock as incentive shares.

On March 5, 2008, we agreed to amend the terms of the note. Pursuant to the
terms of the amended note, payments made by us in satisfaction of the note
will be in shares of our common stock, which we will issue to Dutchess on the
tenth calendar day of each month until our obligations under the note have
been satisfied in full.  Each payment will be convertible at eighty percent
of the lowest closing best bid prices of our common stock for the ten trading
days prior to the payment due date.  The maturity date of the note remains the
same. As of March 5, 2008, we owed $632,500 on the note.
The foregoing description of the terms and conditions of the promissory note
is qualified in its entirety by, and made subject to, the more complete
information set forth in the Convertible Promissory Note filed as Exhibit 4.29,
to the Form 10-KSB filed December 12, 2006 and incorporated herein by
reference.  The foregoing description of the terms and conditions of the
amended promissory note is qualified in its entirety by, and made subject
to, the more complete information set forth in the Amended Convertible
Promissory Note filed as Exhibit 4.2 and incorporated herewith.

This report may contain forward-looking statements that involve risks and
uncertainties.  You should not place undue reliance on these forward-looking
statements.  Our actual results could differ materially from those anticipated
in the forward-looking statements for many reasons including the risks
described in our annual report on Form 10-K and other filings we make from
time to time filed with the Securities and Exchange Commission. Although we
believe the expectations reflected in the forward-looking statements are
reasonable, they relate only to events as of the date on which the statements
are made.  We do not intend to update any of the forward-looking statements
after the date of this document to conform these statements to actual results
or to changes in our expectations, except as required by law.

ITEM 9.01               EXHIBITS.

EXHIBIT
NUMBER                              DESCRIPTION

4.1     Convertible Promissory Note between the Company and Dutchess Private
        Equities Fund, L.P., dated December 6, 2006 (included as Exhibit 4.29
        to the Form 10-KSB filed December 12, 2006 and incorporated herein
        by reference).

4.2     Amended Convertible Promissory Note between the Company and Dutchess
        Private Equities Fund, L.P., dated March 5, 2008 (filed herewith).

                                     SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                          On The Go Healthcare, Inc.
                                          --------------------------
                                                (Registrant)

Date    March 6, 2008

                                               /s/ Stuart Turk
                                          --------------------------
                                                 (Signature)

                                           Name: Stuart Turk
                                          Title: Chief Executive Officer and
                                                 President